338 related articles for article (PubMed ID: 33446122)
1. Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis.
Li Z; Zhuang H; Wang G; Wang H; Dong Y
BMC Infect Dis; 2021 Jan; 21(1):74. PubMed ID: 33446122
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center.
Mahajan SN; Shah JN; Hachem R; Tverdek F; Adachi JA; Mulanovich V; Rolston KV; Raad II; Chemaly RF
Oncologist; 2012; 17(10):1329-36. PubMed ID: 22707509
[TBL] [Abstract][Full Text] [Related]
3. Emergence of community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated bloodstream infections in Korea.
Park SH; Park C; Yoo JH; Choi SM; Choi JH; Shin HH; Lee DG; Lee S; Kim J; Choi SE; Kwon YM; Shin WS
Infect Control Hosp Epidemiol; 2009 Feb; 30(2):146-55. PubMed ID: 19128184
[TBL] [Abstract][Full Text] [Related]
4. Evolving Epidemiology of Staphylococcus aureus Bacteremia.
Rhee Y; Aroutcheva A; Hota B; Weinstein RA; Popovich KJ
Infect Control Hosp Epidemiol; 2015 Dec; 36(12):1417-22. PubMed ID: 26372679
[TBL] [Abstract][Full Text] [Related]
5. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.
Burton DC; Edwards JR; Horan TC; Jernigan JA; Fridkin SK
JAMA; 2009 Feb; 301(7):727-36. PubMed ID: 19224749
[TBL] [Abstract][Full Text] [Related]
6. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of bloodstream infections caused by methicillin-resistant Staphylococcus aureus at a tertiary care hospital in New York.
Yasmin M; El Hage H; Obeid R; El Haddad H; Zaarour M; Khalil A
Am J Infect Control; 2016 Jan; 44(1):41-6. PubMed ID: 26412481
[TBL] [Abstract][Full Text] [Related]
8. Trends in Incidence of Methicillin-resistant Staphylococcus aureus Bloodstream Infections Differ by Strain Type and Healthcare Exposure, United States, 2005-2013.
See I; Mu Y; Albrecht V; Karlsson M; Dumyati G; Hardy DJ; Koeck M; Lynfield R; Nadle J; Ray SM; Schaffner W; Kallen AJ
Clin Infect Dis; 2020 Jan; 70(1):19-25. PubMed ID: 30801635
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, clinical characteristics and treatment outcomes of healthcare- associated methicillin-resistant Staphylococcus aureus BLOODSTREAM infections at Chiang Mai University Hospital: a retrospective study.
Chaiwarith R; Pacharasupal P; Sirisanthana T
Southeast Asian J Trop Med Public Health; 2014 Jul; 45(4):897-905. PubMed ID: 25427359
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and clinical characteristics of Staphylococcus aureus bloodstream infections in a tertiary-care center in Mexico City: 2003-2007.
Ponce-de-León A; Camacho-Ortiz A; Macías AE; Landín-Larios C; Villanueva-Walbey C; Trinidad-Guerrero D; López-Jácome E; Galindo-Fraga A; Bobadilla-del-Valle M; Sifuentes-Osornio J
Rev Invest Clin; 2010; 62(6):553-9. PubMed ID: 21416781
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study.
Seas C; Garcia C; Salles MJ; Labarca J; Luna C; Alvarez-Moreno C; Mejía-Villatoro C; Zurita J; Guzmán-Blanco M; Rodríguez-Noriega E; Reyes J; Arias CA; Carcamo C; Gotuzzo E;
J Antimicrob Chemother; 2018 Jan; 73(1):212-222. PubMed ID: 29045648
[TBL] [Abstract][Full Text] [Related]
12. Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: no better than a coin toss.
Herzke CA; Chen LF; Anderson DJ; Choi Y; Sexton DJ; Kaye KS
Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1057-61. PubMed ID: 19803766
[TBL] [Abstract][Full Text] [Related]
13. [Risk factors and antibiotic use in methicillin-resistant Staphylococcus aureus bacteremia in hospitalized patients at Hacettepe University Adult and Oncology Hospitals (2004-2011) and antimicrobial susceptibilities of the isolates: a nested case-control study].
Atmaca O; Zarakolu P; Karahan C; Cakır B; Unal S
Mikrobiyol Bul; 2014 Oct; 48(4):523-37. PubMed ID: 25492648
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.
Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Molina J; Lopez-Medrano F; Ruiz E; Martinez JA; Bereciartua E; Rodriguez-Lopez F; Fernandez-Mazarrasa C; Goenaga MA; Benito N; Rodriguez-Baño J; Espejo E; Pujol M;
Clin Microbiol Infect; 2013 Nov; 19(11):1049-57. PubMed ID: 23331461
[TBL] [Abstract][Full Text] [Related]
15. A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe.
Hassoun-Kheir N; Guedes M; Ngo Nsoga MT; Argante L; Arieti F; Gladstone BP; Kingston R; Naylor NR; Pezzani MD; Pouwels KB; Robotham JV; Rodríguez-Baño J; Tacconelli E; Vella V; Harbarth S; de Kraker MEA;
Clin Microbiol Infect; 2024 Mar; 30 Suppl 1():S14-S25. PubMed ID: 37802750
[TBL] [Abstract][Full Text] [Related]
16. Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.
Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chen WJ; Chang SC; Hsueh PR
Clin Infect Dis; 2012 Nov; 55(10):1329-37. PubMed ID: 22911641
[TBL] [Abstract][Full Text] [Related]
17. Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States.
Kourtis AP; Hatfield K; Baggs J; Mu Y; See I; Epson E; Nadle J; Kainer MA; Dumyati G; Petit S; Ray SM; ; Ham D; Capers C; Ewing H; Coffin N; McDonald LC; Jernigan J; Cardo D
MMWR Morb Mortal Wkly Rep; 2019 Mar; 68(9):214-219. PubMed ID: 30845118
[TBL] [Abstract][Full Text] [Related]
18. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia.
Roghmann MC
Arch Intern Med; 2000 Apr; 160(7):1001-4. PubMed ID: 10761966
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus bacteremia in an Indian tertiary care hospital: observational study on clinical epidemiology, resistance characteristics, and carriage of the Panton-Valentine leukocidin gene.
Eshwara VK; Munim F; Tellapragada C; Kamath A; Varma M; Lewis LE; Mukhopadhyay C
Int J Infect Dis; 2013 Nov; 17(11):e1051-5. PubMed ID: 23891294
[TBL] [Abstract][Full Text] [Related]
20. Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.
Joo J; Yamaki J; Lou M; Hshieh S; Chu T; Shriner KA; Wong-Beringer A
Clin Ther; 2013 Jul; 35(7):995-1004. PubMed ID: 23829982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
